Healio (6/15, VanDewater) reports, “Among patients with multiple sclerosis” (MS), “cognitive function was predicted by age, depressive symptoms and anxiety,” researchers concluded after retrospectively reviewing “charts for 802 consecutive adult patients with MS who attended a tertiary neuropsychiatry clinic from 2006 to 2022.” The study revealed that “in younger people with MS, the core depressive symptoms were particularly predictive of cognitive impairment, while in older adults with MS, it’s more so the anxious distress in the context of depression that is predictive of cognitive impairment.” The findings were presented in a poster at the American Psychiatric Association 2023 Annual Meeting.

Related Links:

— “Cognition in multiple sclerosis depends on patients’ depression, anxiety, age,” Kalie VanDewater, Healio, June 15, 2023

CNN (6/15, Howard) says, “The proportion of US adults who have ever been diagnosed with depression ranges greatly depending on where they live.” Research published online June 16 in the CDC’s Morbidity and Mortality Weekly Report “finds that in 2020, 18.4% of US adults reported having ever been diagnosed with depression in their lifetimes – but, state by state, that percentage of adults ranged from an estimated 12.7% in Hawaii to 27.5% in West Virginia.” The researchers wrote, “There was considerable geographic variation in the prevalence of depression, with the highest state and county estimates of depression observed along the Appalachian and southern Mississippi Valley regions.” For this research, the team “analyzed data from the CDC’s Behavioral Risk Factor Surveillance System.” AAP President Rebecca Brendel, MD, JD, commented, “The fact that Americans are more depressed and struggling after this time of incredible stress and isolation is perhaps not surprising. … There are lingering effects on our health, especially our mental health, from the past three years that disrupted everything we knew.”

HealthDay (6/15, Mundell) reports, “Find out more about the signs of depression at the American Psychiatric Association.”

Related Links:

— “Nearly 1 in 5 US adults have been diagnosed with depression and the prevalence varies dramatically by state, CDC report finds,” Jacqueline Howard, CNN, June 15, 2023

— “Are You Living in One of America’s Most Depressed States?,” Ernie Mundell, HealthDay, June 15, 2023

According to MedPage Today (6/14, George), “prescription stimulants used as cognitive enhancers by people without” attention-deficit/hyperactivity disorder (AD/HD)” appear to reduce “performance in complex everyday activities,” investigators concluded in the findings of a 40-participant, “double-blind randomized trial.” The cognitive enhancers studied included methylphenidate (Ritalin), dextroamphetamine (Dexedrine), and modafinil (Provigil).”

HealthDay (6/14, Thompson) reports that subjects of the study “took much longer to complete tasks because they acted in a more erratic, scattershot manner while they worked.” The findings were published online June 14 in the journal Science Advances.

Related Links:

— MedPage Today (requires login and subscription)

— “For Folks Without the Condition, Taking ADHD Meds to Get ‘Smarter’ Could Backfire,” Dennis Thompson, HealthDay, June 14, 2023

Psychiatric News (6/14) reports, “Calls to hundreds of child psychiatrists listed as in-network with Blue Cross-Blue Shield (BCBS) in three major U.S. cities led to appointments for children just 11% of the time,” investigators concluded in a study in which researchers “called 322 psychiatrists listed as in-network by Blue Cross-Blue Shield in Chicago, Houston, and Los Angeles and impersonated the parent of a 10-year-old child who had just visited the emergency department for depression.” Taking a “secret shopper” approach, the researchers “asked for an appointment using a standardized script that varied only according to how they intended to pay for the services: BCBS, Medicaid, or self-pay.” The findings were published online June 8 in a brief report in the journal Psychiatric Services, a publication of the American Psychiatric Association.

Related Links:

— “Survey Reveals Stark Difficulty in Obtaining Appointments With Child Psychiatrists,” Psychiatric News, June , 202314

CNN (6/15, McPhillips) reports, “In 2021, suicide and homicide rates for children and young adults ages 10 to 24 in the US were the highest they’ve been in decades, according to a new report from the US Centers for Disease Control and Prevention.” The report found that “suicide and homicide were the second and third leading causes of death for this age group,” while “the homicide rate for this age group in 2021 was the highest it’s been since 1997, and the suicide rate was the highest on record, since 1968.”

Related Links:

— “Youth, young adults are dying from suicide and homicide at highest rates in decades, CDC report says,” Deidre McPhillips, CNN, June 15, 2023